Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Drug combinations comprising a DGAT inhibitor and a PPAR-agonist

Drug combinations comprising a DGAT inhibitor and a PPAR-agonist

US Patent 9107946 · Granted Aug 18, 2015

Estimated economic value: $133,323,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehyd2017
Drug combinations comprising a DGAT inhibitor and a PPAR-agonist2017
Drug combinations comprising a DGAT inhibitor and a PPAR-agonist2017
Drug combinations comprising a DGAT inhibitor and a PPAR-agonist2017
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2017
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Piperidine/piperazine derivatives2016
Piperidine/piperazine derivatives2016
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2015
Benzocycloheptane and benzoxepine derivatives2015
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehyd2015